Is HER2/neu overexpression a predictor of anthracycline utility?
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D011237:Predictive Value of Tests; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*
D000903:Antibiotics, Antineoplastic; D018719:Erb-b2 Receptor Tyrosine Kinases